QUARTERLY RESULTS OF OPERATIONS (UNAUDITED)

The following is a summary of the quarterly results of operations for the years ended December 31, 1996 and 1995. (in thousands, except per share data)

First
Quarter
 Second
Quarter
 Third   
Quarter (1)		 Fourth        
Quarter (2)(3)(4)		 Year
1996
Net sales $266,000 $283,600 $280,000    $283,100          $1,112,700
Cost of products sold 112,200 116,800 116,100    115,500          460,600
Income before income taxes 27,100 35,300 38,000    41,300          141,700
Net income 20,900 27,200 29,200    31,800          109,100
Net income per common
share (primary and fully diluted)		 $.28 $.38 $.39    $.43          $1.48
1995
Net sales $240,600 $263,600 $254,800    $263,300          $1,022,300
Cost of products sold 112,900 117,800 106,500    114,500          451,700
Income before income taxes 18,700 24,800 20,600    25,700          89,800
Net income 14,400 19,100 25,900    19,800          79,200
Net income per common
share (primary and fully diluted)		 $.17 $.25 $.37    $.26          $1.05

(1)In the third quarter of 1995, the Company reached an agreement with respect to the settlement of all issues raised by the Internal Revenue Service in the examination of the Company's income tax returns for the years 1984 through 1990. As a result of the agreement, the Company recognized a net credit to the tax provision of $10 million ($ .18 per common share) in the third quarter of 1995.
(2)The fourth quarter of 1996 contains three months of subsidiary operations of the Company's Japanese subsidiary as compared to the fourth quarter of 1995 which contained two months of subsidiary operations. In November 1995 the Company's Japanese subsidiary adopted a November 30 year end to be consistent with the fiscal year end of other subsidiaries and, accordingly, recorded only two months of Japanese subsidiary operations in the fourth quarter of 1995.
(3)Sales were adversely effected in the fourth quarter 1996 by changes in reimbursement to French public hospitals by France's Social Security Administration. Despite the reduction in reimbursement, sales in France are expected to increase in 1997 when compared to 1996 sales.
(4)Cost of products sold in the fourth quarter of 1995 includes $13 million of inventory and fixed asset reserves resulting from the continued introduction of new products and the consequent obsolescence of production tooling and inventories.

home | surgeons | nurses | hospital administrators | reference room | did you know? | about USSC

Trademarks of United States Surgical Corporation and its subsidiaries throughout this publication are italicized.
Copyright © 1997 United States Surgical Corporation. All Rights Reserved.
Contact webteam